CARMIL2 (capping protein regulator and myosin 1 linker 2)

2001-01-01  

Identity

HGNC
LOCATION
16q22.1
LOCUSID
ALIAS
CARMIL2b,IMD58,LRRC16C,RLTPR

Other Information

Locus ID:

NCBI: 146206
MIM: 610859
HGNC: 27089
Ensembl: ENSG00000159753

Variants:

dbSNP: 146206
ClinVar: 146206
TCGA: ENSG00000159753
COSMIC: CARMIL2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000159753ENST00000334583Q6F5E8
ENSG00000159753ENST00000545661Q6F5E8
ENSG00000159753ENST00000602368R4GMZ7
ENSG00000159753ENST00000602563R4GNC4

Expression (GTEx)

0
5
10
15
20
25
30
35
40
45
50

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
365156782023Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency.6
365156782023Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency.6
330986962021RLTPR Q575E: A novel recurrent gain-of-function mutation in patients with adult T-cell leukemia/lymphoma.2
337233092021Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel disease.6
330986962021RLTPR Q575E: A novel recurrent gain-of-function mutation in patients with adult T-cell leukemia/lymphoma.2
337233092021Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel disease.6
314109262020Synaptic actin stabilization protein loss in Down syndrome and Alzheimer disease.23
322019382020Exogenous interleukin-2 can rescue in-vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutation.9
326251992020A Novel Pathogenic Variant in CARMIL2 (RLTPR) Causing CARMIL2 Deficiency and EBV-Associated Smooth Muscle Tumors.16
314109262020Synaptic actin stabilization protein loss in Down syndrome and Alzheimer disease.23
322019382020Exogenous interleukin-2 can rescue in-vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutation.9
326251992020A Novel Pathogenic Variant in CARMIL2 (RLTPR) Causing CARMIL2 Deficiency and EBV-Associated Smooth Muscle Tumors.16
310017062019A Novel CARMIL2 Mutation Resulting in Combined Immunodeficiency Manifesting with Dermatitis, Fungal, and Viral Skin Infections As Well as Selective Antibody Deficiency.17
310792702019A Unique Presentation of Infantile-Onset Colitis and Eosinophilic Disease without Recurrent Infections Resulting from a Novel Homozygous CARMIL2 Variant.12
311154542019CARMIL2 Deficiency Presenting as Very Early Onset Inflammatory Bowel Disease.15

Citation

Dessen P

CARMIL2 (capping protein regulator and myosin 1 linker 2)

Atlas Genet Cytogenet Oncol Haematol. 2001-01-01

Online version: http://atlasgeneticsoncology.org/gene/78439/carmil2-(capping-protein-regulator-and-myosin-1-linker-2)